| PARC report: a health-systems focus on reimbursement and patient access to pharmacogenomics testing S L Rogers, NJ Keeling, J Giri, N Gonzaludo, JS Jones, E Glogowski, ... Pharmacogenomics 21 (11), 785-796, 2020 | 20 | 2020 |
| Clinical pharmacogenomics of carvedilol: the stereo-selective metabolism angle BM Parker, SL Rogers, A Lymperopoulos Pharmacogenomics 19 (14), 1089-1093, 2018 | 12 | 2018 |
| PARC report: Health outcomes and value of personalized medicine interventions: Impact on patient care C Mitropoulou, V Litinski, B Kabakchiev, S Rogers, G P Patrinos Pharmacogenomics 21 (11), 797-807, 2020 | 9 | 2020 |
| PARC report: a perspective on the state of clinical pharmacogenomics testing J Eichmeyer, S Rogers, CM Formea, J Giri, JS Jones, E Schnettler, ... Pharmacogenomics 21 (11), 809-820, 2020 | 7 | 2020 |
| Dispelling The Myths About Outcome-Based Reforms WG Spady, K Marshal, S Rogers Initially presented at The American Association of School Administrators …, 1996 | 5 | 1996 |
| Differentiating Pseudoprogression From Hyperprogression in Patients Treated With Immunotherapies K Patel, H Mukhi, A Patel, D Mehta, N Clinton, WO Sara Rogers, P Reddy | 2 | 2022 |
| Application of the community dialogues method to identify ethical values and priorities related to pharmacogenomics P Determeyer, J Crowder, E O'Mahony, B Esquivel, H Atwal, PS Atwal, ... Pharmacogenomics 22 (11), 693-701, 2021 | 2 | 2021 |
| The Current State of Pharmacoeconomics and Reimbursement for Pharmacogenomics SL Rogers Advances in Molecular Pathology, 2023 | 1 | 2023 |
| Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine … AA Aziz, S Rogers, O Hassanien, L Shalaby, M Nagy Personalized Medicine 19 (6), 495-507, 2022 | 1 | 2022 |
| “Technology is Wonderful Until It Isn't”: Community-Based Research and the Precarity of Digital Infrastructure J Crowder, P Determeyer, S Rogers The Routledge Companion to Media Anthropology, 77-88, 2022 | 1 | 2022 |
| Recommendations for pharmacogenetic testing in clinical practice guidelines in the US DL Hertz, CA Bousman, HL McLeod, AA Monte, D Voora, LA Orlando, ... American Journal of Health-System Pharmacy, zxae110, 2024 | | 2024 |
| Classification, Diagnosis, and Medical Treatment of Pulmonary Hypertension A Tenpas, L Panahi, G Udeani, C Ogbodo, J Alonzo, AC Mingle, P Patel, ... IntechOpen, 2024 | | 2024 |
| Case Report: Life-Threatening Fluoxetine-Linked Postoperative Bleeding Informed by Pharmacogenetic Evaluation S Rogers, PJ Silva, G Udeani, M Deleon, S Mutyala, L Panahi, ... Drugs in R&D, 1-5, 2024 | | 2024 |
| Ontology anchored decision support tools: A focus on pharmacogenomics RB Guerrero, K Marshall, S Rogers, M Weissman Elsevier, 2023 | | 2023 |
| Addressing Cancer Health Disparities in a Multilateral Collaboration in an Independent Community Cancer Clinic: Translating Words Into Action TO Kashyap Patel, Hirangi Mukhi, Anjana Patel, Niyati Nathwani, Dhwani Mehta ... American Journal of Managed Care 28 (6), 2022 | | 2022 |
| Conference report: inaugural Pharmacogenomics Access & Reimbursement Symposium SL Rogers, GP Patrinos, C Mitropoulou, CM Formea, J Shawn Jones, ... The Pharmacogenomics Journal 21 (5), 622-624, 2021 | | 2021 |
J. Shawn JonesAssociate Professor, Texas Tech University Health Science Center Hodge School of PharmacyVerified email at ttuhsc.edu
